MarketsandMarkets is proud to announce the 2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress to be held on 24th-25th October 2019 in Boston, USA. With the increasing recognition of real-world data opportunities and challenges within the pharmaceutical and biotech industry, life sciences organizations face clear decisions on how specifically to put resources into real-world evidence capacities.
Real-World Evidence can possibly change the way life sciences associations use advancements to increase further clinical bits of knowledge and enable them and payers to collaborate like never before. After the successful inaugural, the 2nd Annual Real-World Data and Life Science Analytics Congress will hold discussions on accelerating the adoption of Real-world evidence within the industry while understanding the capabilities of newer technologies for evidence generation. The congress will also address upcoming changes in the regulatory landscape with the recent framework by the FDA.
Our aim for the 2nd Annual Real-World Data and Life Science Analytics Congress is to unite all stakeholders to see how to use conventional informational indexes and layer that in with innovative analytical techniques and new working models.